Clinical trial
Dose-Ranging Study in Patients With COPD
NCT00098228 is registered in ClinicalTrials.gov with Novartis Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Dose-Ranging Study in Patients With COPD
- Lead sponsor
- Novartis Pharmaceuticals
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- July 31, 2004
- Completion date
- December 31, 2004
- Enrollment
- 686 (actual)
- Sites
- 54
Conditions
As the registry lists them; a condition with its own page is linked.
copd